Primary Investigator:
Katherine Tuttle, MD

Description:
The purpose of this study is to test whether reducing cholesterol can prevent heart disease and strokes in patients with Chronic Kidney Disease.

Eligibility:

• Men or women age 40 years of age
• Pre-dialysis Creatinine - 1.7 mg/dL in men or 1.5 mg/dL in women
• On dialysis
• Does not require statin therapy
• Other Eligibilty criterea may apply. PLease contact study coordinator

Exclusions:

• History of coronary artery disease
• Chronic liver disease
• Adverse reaction to a statin or ezetimibe

Study Timeline:
Closed to enrollment

Study Contact:
Sandra RN,MN,CCRC Sandra.Albritt@providence.org

Study Sponsor:
Oxford University